All these information tempted us to render insight into the existence of an interactive relationship between SMAR1, p53, Cox-2 and HIF1-α, if any, that decides fate of VEGF expression during tumor angiogenesis in NSCLC. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.